NCT01305200 · OUTCOME
Duration of Severe Oral Mucositis (WHO Grade 3 or 4)
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEAN
- Unit
- Number of days
- Interval / dispersion
- Standard Deviation
- Time frame
- Day -1 (day prior to stem cell infusion) to Day 20 following transplantation.
What was measured
Mean days of severe (WHO Grade 3 or 4) Mucositis.
Analysis population: Evaluable patients defined as patients with \>= 11 daily WHO assessments.
Groups in this outcome
Arm I (Placebo)
Patients rinse and gargle with placebo over 1 minute QID beginning the first day (about day -7) of the conditioning regimen. Treatment continues until day 20 post-transplantation. placebo: Mouth rinse questionnaire administration: Ancillary studies quality-of-life assessment: Ancillary studies
Arm II (Supersaturated Calcium Phosphate Rinse)
Patients rinse and gargle with supersaturated calcium phosphate rinse over 1 minute QID beginning on the first day (about day -7) of the conditioning regimen. Treatment continues until day 20 post-transplantation. supersaturated calcium phosphate rinse: Mouth rinse questionnaire administration: Ancillary studies quality-of-life assessment: Ancillary studies
| Group | Source count |
|---|---|
| Arm I (Placebo) | 91 |
| Arm II (Supersaturated Calcium Phosphate Rinse) | 91 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Arm I (Placebo) | 4.5 | 4.8 | Not reported | Not reported | Not reported |
| Arm II (Supersaturated Calcium Phosphate Rinse) | 4.5 | 5 | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- spread
- 4.8
- value
- 4.5
- group Id
- OG001
- spread
- 5
- value
- 4.5
- denoms
- counts
- group Id
- OG000
- value
- 91
- group Id
- OG001
- value
- 91
- units
- Participants
- description
- Mean days of severe (WHO Grade 3 or 4) Mucositis.
- dispersion Type
- Standard Deviation
- groups
- description
- Patients rinse and gargle with placebo over 1 minute QID beginning the first day (about day -7) of the conditioning regimen. Treatment continues until day 20 post-transplantation. placebo: Mouth rinse questionnaire administration: Ancillary studies quality-of-life assessment: Ancillary studies
- id
- OG000
- title
- Arm I (Placebo)
- description
- Patients rinse and gargle with supersaturated calcium phosphate rinse over 1 minute QID beginning on the first day (about day -7) of the conditioning regimen. Treatment continues until day 20 post-transplantation. supersaturated calcium phosphate rinse: Mouth rinse questionnaire administration: Ancillary studies quality-of-life assessment: Ancillary studies
- id
- OG001
- title
- Arm II (Supersaturated Calcium Phosphate Rinse)
- param Type
- MEAN
- population Description
- Evaluable patients defined as patients with \>= 11 daily WHO assessments.
- reporting Status
- POSTED
- time Frame
- Day -1 (day prior to stem cell infusion) to Day 20 following transplantation.
- title
- Duration of Severe Oral Mucositis (WHO Grade 3 or 4)
- type
- PRIMARY
- unit Of Measure
- Number of days
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle